Ligand profile
IMH
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0569 — ribonucleoside hydrolase 1
Identifiers
Database identifiers and provenance.
- Ligand ID
IMH- PDB
6zk2- UniProt (similar protein)
B6THD4- Target protein
- VK055_0569
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 134.3
- −1 ≤ LogP ≤ 5 -2.02
- MW ≤ 500 Da 266.3
- LogP ≤ 5 -2.02
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 134.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1c(c2c([nH]1)C(=O)NC=N2)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)Oc1c(c2c([nH]1)C(=O)NC=N2)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
InChI=1S/C11H14N4O4/c16-2-5-9(17)10(18)7(15-5)4-1-12-8-6(4)13-3-14-11(8)19/h1,3,5,7,9-10,12,15-18H,2H2,(H,13,14,19)/t5-,7+,9-,10+/m1/s1InChI=1S/C11H14N4O4/c16-2-5-9(17)10(18)7(15-5)4-1-12-8-6(4)13-3-14-11(8)19/h1,3,5,7,9-10,12,15-18H,2H2,(H,13,14,19)/t5-,7+,9-,10+/m1/s1
IWKXDMQDITUYRK-KUBHLMPHSA-NIWKXDMQDITUYRK-KUBHLMPHSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01156
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand IMH →
- PDB RCSB structure 6zk2 →
- UniProt UniProt B6THD4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “IMH”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0569.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).